Search
Search
About
Log in
Join
Experiences with
Targeted therapy
Posts
Communities
16,666 public posts
Filter results
Thank you Angela for sharing your story!
Shortly after returning home from hospital I started on
targeted
therapy
to treat my melanoma which has been working really well ever since.
Shortly after returning home from hospital I started on
targeted
therapy
to treat my melanoma which has been working really well ever since.
SkcinHQ
Partner
in
Skin Cancer UK
3 months ago
Research Participation Opportunity!
therapy
(such as Lynparza, Rubraca, and Zejula) Those who qualify and complete the virtual interview will be paid $125 USD if you are a US participant and £80 GBP if you are a UK participant.
therapy
(such as Lynparza, Rubraca, and Zejula) Those who qualify and complete the virtual interview will be paid $125 USD if you are a US participant and £80 GBP if you are a UK participant.
SHAREPrograms
Partner
in
SHARE Ovarian Cancer Support
7 months ago
ONLINE SUPPORT GROUPS
As this is quite a specific group who are on
targeted
therapy
, it is nice to have people who are in a similar boat. [u]New group starting on Wednesday 20th of March. [/u]This group will run weekly for 8 weeks every Wednesday evening - 6.30-7.30pm.
As this is quite a specific group who are on
targeted
therapy
, it is nice to have people who are in a similar boat. [u]New group starting on Wednesday 20th of March. [/u]This group will run weekly for 8 weeks every Wednesday evening - 6.30-7.30pm.
ConnectRoyCastle
Administrator
in
The Roy Castle Lung Cancer Foundation
7 months ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Lutetium at earlier stage, clinical trial is enrolling
The second trial provides men with metastatic prostate cancer access to prostate-specific membrane antigen (PSMA)-
targeted
therapy
prior to chemotherapy. Currently, PSMA-
targeted
therapy
is only available after chemotherapy.
The second trial provides men with metastatic prostate cancer access to prostate-specific membrane antigen (PSMA)-
targeted
therapy
prior to chemotherapy. Currently, PSMA-
targeted
therapy
is only available after chemotherapy.
Maxone73
in
Advanced Prostate Cancer
5 months ago
Transformation of Richter's Transformation Treatment to combination targeted therapy - tislelizumab +zanubrutinib (ASH 2023)
Richter's Transformation treatments are typically fixed term R-CHOP*, or modifications of that chemoimmunity therapy. So it's encouraging to hear that [i]"In a phase 2 trial, anti-PD-1 inibitor tislelizumab + next gen BTK inhibitor zanubrutinib had an overall response rate of 58.3% in patients with Richter's
Richter's Transformation treatments are typically fixed term R-CHOP*, or modifications of that chemoimmunity therapy. So it's encouraging to hear that [i]"In a phase 2 trial, anti-PD-1 inibitor tislelizumab + next gen BTK inhibitor zanubrutinib had an overall response rate of 58.3% in patients with Richter's
AussieNeil
Partner
in
CLL Support
9 months ago
DENOSUNAB
However, as my
targeted
therapy
treatment (Brigatinib) is working, I am enquiring whether it is still necessary for me to continue with the Denosunab, and if I do have to, the possible reasons why?
However, as my
targeted
therapy
treatment (Brigatinib) is working, I am enquiring whether it is still necessary for me to continue with the Denosunab, and if I do have to, the possible reasons why?
Gymbuddie
in
The Roy Castle Lung Cancer Foundation
10 months ago
List of good Genetic Tests in Homologous Recombination Deficiency in PCa and the Mechanisms of Resistance to PARP Inhibitors
Another challenging issue is the development of effective biomarkers to identify patients who are more likely to respond to specific
therapy
by using companion diagnosis (CDx).
Another challenging issue is the development of effective biomarkers to identify patients who are more likely to respond to specific
therapy
by using companion diagnosis (CDx).
KocoPr
in
Advanced Prostate Cancer
3 months ago
What is role of hormonal therapy drug when taken with targeted therapy, eg Piqray or Ibrance?
I want to better understand the role of the hormone
therapy
eg Faslodex when taken with
targeted
therapy
such as Ibrance. Does it just reduce the amount of estrogen available to the cell and “lightens the load” on the
targeted
therapy
? Or is there a more complex interaction between the two drugs?
I want to better understand the role of the hormone
therapy
eg Faslodex when taken with
targeted
therapy
such as Ibrance. Does it just reduce the amount of estrogen available to the cell and “lightens the load” on the
targeted
therapy
? Or is there a more complex interaction between the two drugs?
HelenWi
in
SHARE Metastatic Breast Cancer
11 months ago
Feeling Right
I've had OCD
targeted
therapy
including groups with the Anxiety and Panic Treatment Center in Portland, OR, which kind of helped for a while. I do see a family oriented therapist for other issues.
I've had OCD
targeted
therapy
including groups with the Anxiety and Panic Treatment Center in Portland, OR, which kind of helped for a while. I do see a family oriented therapist for other issues.
Stratocaster78
in
My OCD Community
8 months ago
Targeted therapy drugs
I am interested in people who have taken Zanubrutinib. Did you half to go through a lot of hassle getting the drug? How many preliminary’s are involved before they say OK? I am interested in the stories of individuals that have taken the drug.
I am interested in people who have taken Zanubrutinib. Did you half to go through a lot of hassle getting the drug? How many preliminary’s are involved before they say OK? I am interested in the stories of individuals that have taken the drug.
Tupelomojo
in
CLL Support
1 year ago
Update on trametinib (Mekinist) for low grade serous ovarian cancer
Trametinib is a
targeted
therapy
which blocks a protein that helps cancer cells grow. Off-label drugs are prescribed by doctors in a different way than the conditions in its licence.
Trametinib is a
targeted
therapy
which blocks a protein that helps cancer cells grow. Off-label drugs are prescribed by doctors in a different way than the conditions in its licence.
OvacomeSupport
My Ovacome Team
in
My Ovacome
10 months ago
recurrence after lobectomy
I begged for adjuvant therapy after the operation as I was terrified to find out in the histology report that the only mutation found was Kras G12V (with more risks of recurrence and very bad prognosis in case of recurrence (no
targeted
therapy
etc).
I begged for adjuvant therapy after the operation as I was terrified to find out in the histology report that the only mutation found was Kras G12V (with more risks of recurrence and very bad prognosis in case of recurrence (no
targeted
therapy
etc).
Bibicata
in
The Roy Castle Lung Cancer Foundation
9 months ago
LUNG CANCER TREATMENT SUPPORT
[/i]
This new support group is aimed at those in active treatment whatever that may be, surgery, chemo, immunotherapy, radiotherapy,
therapy
.
[/i]
This new support group is aimed at those in active treatment whatever that may be, surgery, chemo, immunotherapy, radiotherapy,
therapy
.
ConnectRoyCastle
Administrator
in
The Roy Castle Lung Cancer Foundation
1 year ago
Genomics
Only because
targeted
therapy
is in its infancy, trials required to identify best treatments. https://www.biospace.com/article/releases/epic-sciences-unveils-definembc-a-novel-blood-based-test-designed-to-improve-care-for-metastatic-breast-cancer-patients/ 🙏🏻
Only because
targeted
therapy
is in its infancy, trials required to identify best treatments. https://www.biospace.com/article/releases/epic-sciences-unveils-definembc-a-novel-blood-based-test-designed-to-improve-care-for-metastatic-breast-cancer-patients/ 🙏🏻
muzzatron
in
SHARE Metastatic Breast Cancer
11 months ago
Bayer Starts Phase I Study With Novel Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer
225Ac-PSMA-Trillium (BAY 3563254) is an investigational next-generation PSMA-
targeted
alpha
therapy
with potential to treat patients with advanced metastatic prostate cancer Prostate cancer is the second most commonly diagnosed cancer in men1, with less than three years median survival among metastatic
225Ac-PSMA-Trillium (BAY 3563254) is an investigational next-generation PSMA-
targeted
alpha
therapy
with potential to treat patients with advanced metastatic prostate cancer Prostate cancer is the second most commonly diagnosed cancer in men1, with less than three years median survival among metastatic
God_Loves_Me
in
Advanced Prostate Cancer
3 months ago
Actinic keratosis & Lung cancer
Surely having the skin patch could be treated without affecting his
targeted
therapy
for lung cancer?? Thank you.
Surely having the skin patch could be treated without affecting his
targeted
therapy
for lung cancer?? Thank you.
Adaughter
in
The Roy Castle Lung Cancer Foundation
1 year ago
Phase 1/2 of TLX592 Targeted Alpha Therapy in Prostate Cancer starting soon - Ac 225
https://www.prnewswire.com/news-releases/telix-completes-proof-of-concept-study-of-tlx592-
targeted
-alpha-
therapy
-in-prostate-cancer-302150652.html
https://www.prnewswire.com/news-releases/telix-completes-proof-of-concept-study-of-tlx592-
targeted
-alpha-
therapy
-in-prostate-cancer-302150652.html
Maxone73
in
Advanced Prostate Cancer
3 months ago
V&R treatment ending and skin blemishes mostly on face.
On Monday I will be taking in the last RITUBIMAB infusion of the 7 months
targeted
therapy
for CLL. I will be treatment-Free. I am both elated and also filled with trepidation. I'm not sure what QUESTIONS to ask my oncologist about what to expect next.
On Monday I will be taking in the last RITUBIMAB infusion of the 7 months
targeted
therapy
for CLL. I will be treatment-Free. I am both elated and also filled with trepidation. I'm not sure what QUESTIONS to ask my oncologist about what to expect next.
unairdefamille
in
CLL Support
5 months ago
Targeted Gene Therapy for Symptom Relief in Parkinson’s Disease
https://www.brainpost.co/weekly-brainpost/2023/11/7/
targeted
-gene-
therapy
-for-symptom-relief-in-parkinsons-disease
https://www.brainpost.co/weekly-brainpost/2023/11/7/
targeted
-gene-
therapy
-for-symptom-relief-in-parkinsons-disease
Neurosmith
in
Cure Parkinson's
10 months ago
How prostate cancer transforms into aggressive NEPC following treatment with anti-androgen therapy.
Eventually, over enough time, cancer patients who receive a
targeted
therapy
can become resistant to treatment," says Darren Sigal, M.D., an oncologist at Scripps Clinic and Scripps MD Anderson Cancer Center who worked with the scientists on the study.
Eventually, over enough time, cancer patients who receive a
targeted
therapy
can become resistant to treatment," says Darren Sigal, M.D., an oncologist at Scripps Clinic and Scripps MD Anderson Cancer Center who worked with the scientists on the study.
Scout4answers
in
Advanced Prostate Cancer
10 months ago
1
2
3
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
4593 results
Thyroid UK
2409 results
Endometriosis UK
1881 results
View top 10 communities
Sort by
Most Relevant
Newest